The Bunge Ltd (BG) share price is expected to increase by 18.83% over the next year. This is based on calculating the average 12-month share price estimate provided by 10 stock analysts who have covered BG. Price targets range from $90 at the low end to $129 at the high end. The current analyst consensus for BG is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 10 Wall Street analysts have assigned BG 5 buy ratings, 5 hold ratings, and 0 sell ratings. This means that analysts expect Bunge Ltd to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BG. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BG.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Thomas Palmer Citigroup | Neutral | $114 | Downgrade | Aug 1, 2024 |
Thomas Palmer Citigroup | Buy | $122 | Maintains | Apr 25, 2024 |
Thomas Palmer Citigroup | Buy | $117 | Maintains | Apr 3, 2024 |
Adam Samuelson Goldman Sachs | Buy | $126 | Maintains | Feb 13, 2024 |
Wesley Brooks HSBC | Buy | $105 | Upgrade | Feb 9, 2024 |
Andrew Strelzik BMO Capital | Outperform | $120 | Maintains | Feb 8, 2024 |
Brian Wright Roth MKM | Buy | $138 | Maintains | Feb 5, 2024 |
Thomas Palmer Citigroup | Buy | $108 | Initiates | Feb 1, 2024 |
Adam Samuelson Goldman Sachs | Buy | $141 | Maintains | Jan 24, 2024 |
Ben Kallo Baird | Neutral | $108 | Maintains | Jan 23, 2024 |
Benjamin Theurer Barclays | Overweight | $115 | Maintains | Jan 23, 2024 |
Sam Margolin Wolfe Research | Peer Perform | Downgrade | Jan 10, 2024 | |
Wesley Brooks HSBC | Hold | $122 | Initiates | Sep 15, 2023 |
Manav Gupta UBS | Buy | $141 | Maintains | Aug 7, 2023 |
Vincent Andrews Morgan Stanley | Equal-Weight | $114 | Maintains | Aug 7, 2023 |
Benjamin Theurer Barclays | Overweight | $125 | Maintains | Aug 4, 2023 |
Andrew Strelzik BMO Capital | Outperform | $140 | Maintains | Aug 3, 2023 |
Morgan Stanley | Equal-Weight | Reiterates | Jul 17, 2023 | |
Brian Wright Roth MKM | Buy | $138 | Initiates | Jun 22, 2023 |
Benjamin Theurer Barclays | Overweight | $121 | Maintains | Jun 1, 2023 |
When did it IPO
2001
Staff Count
23,000
Country
United States
Sector/Industry
Consumer Defensive/Farm Products
CEO
Mr. Gregory A. Heckman
Market Cap
$13.84B
In 2023, BG generated $59.54B in revenue, which was a decrease of -11.44% from the previous year. This can be seen as a signal that BG's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Bunge Global SA (NYSE: BG) has completed the sale of its 50% stake in BP Bunge Bioenergia to bp, which now owns 100% of the business.
Why It Matters - Bunge's sale of its stake in BP Bunge Bioenergia could enhance cash flow and refocus resources, impacting its financial health and strategic direction, which are key factors for stock performance.
Summary - BG has sold its 50% stake in a sugar and bioenergy joint venture to BP, citing alignment with its long-term strategic focus.
Why It Matters - BG's divestment from the sugar and bioenergy venture signals a strategic refocus, potentially improving capital allocation and enhancing shareholder value through streamlined operations.
Summary - Bunge Global SA's subsidiary, Bunge Limited Finance Corp., secured consents from 96.5% of holders of its 2.000% and 3.200% Viterra Notes, and 97.6% for its 4.900% Viterra Notes due 2027.
Why It Matters - High consent rates for Bunge's debt restructuring indicate strong investor confidence, potentially leading to improved financial stability and credit ratings, which can influence stock performance.
Summary - The S&P 500 shows high valuations, making bargains scarce. However, three undervalued stocks with strong growth potential and dividends are identified, each at least 40% undervalued.
Why It Matters - High valuations in the S&P 500 make bargain hunting difficult, but identified undervalued stocks with dividends and growth potential offer unique investment opportunities amid a pricey market.
Summary - Investors should monitor Bunge Global (BG) stock due to recent activity in the options market.
Why It Matters - Increased options activity in Bunge Global (BG) can signal investor sentiment and potential volatility, impacting stock price and trading strategies.
Summary - Bunge Global SA has priced a $2.0 billion public offering of senior unsecured notes, including $400 million at 4.1% due 2028 and $800 million at 4.2%, enhancing its financial capacity.
Why It Matters - Bunge's $2 billion bond offering signals strong capital access, potentially funding growth or debt reduction, impacting its financial health and attractiveness to investors.